FAQ
Log In
Saturday 1st October 2016
News
 › 
 › 

Cannabis does not halt MS progression

30th May 2012

Researchers in Plymouth have said taking cannabis pills will not stop or slow the progression of multiple sclerosis. 

cannabis1

The medical trial, carried out by a team at the Peninsula Medical School, gave MS patients pills containing tetrahydrocannabinol (THC) - the active ingredient in the plant - for three years.

While the research, which cost £8 million, showed the pills relieved some MS symptoms, they did not stop the disease progressing.

The study involved 500 MS patients from 27 centres around the UK and was funded by the Medical Research Council (MRC) and managed by the National Institute for Health Research (NIHR).

Professor John Zajicek, the lead researcher on the Cupid (Cannabinoid Use in Progressive Inflammatory brain Disease) trial, said he was "disappointed" with the results on behalf of people with the disease.

He explained: "There's lots of evidence cannabis has a symptomatic effect - it makes people's pain, muscle stiffness and spasms better. But what we were doing in this trial was to see if we could slow down the course of the disease."

"There are very, very few treatments for any neuro-degenerative disease, whether it's Alzheimer's, Parkinson's or progressive multiple sclerosis and we were very much hoping cannabinoid might slow down the progression of the disease as opposed to just ameliorating people's symptoms."

He added that the "holy grail" of researchers was to find the drugs that would slow or stop the progression of neuro-degenerative diseases.

Professor Zajicek presented the results of the trial to the the Association of British Neurologists in Brighton.

 

Share this page

Comments

Steve Hilton

Thursday 31st May 2012 @ 12:42

Firstly I must point out that the headline (which originates from Reuters) is misleading and deceptive. This study looks at just one of the many active and beneficial compounds contained within the cannabis plant. It is not a study on Cannabis at all and should not be tagged as such.



Let's examine a paragraph from this confused report.

"Cannabis contains more than 60 different Cannabinoids, of which THC is thought to be the most active, and many MS patients have long said the drug helps them cope with the effects of the disease."



MS sufferers have used natural, whole, Cannabis for many years and this is what they have reported as being of such benefit. The drug which MS patients have had great benefit is Whole Cannabis: NOT the isolated compound used for this study! It is therefore quite apparent that the study reported here has NOT studied the effects of Cannabis on MS and it's findings are only applicable to isolated THC and NOT to Whole Cannabis.

Old Man Peterson

Thursday 31st May 2012 @ 20:34

So it begins by saying ''Cannabis does not halt MS progression'', thats the headline...as you read on you begin to understand it was not cannabis, it was THC. Yes THC is one of the main constituents in cannabis, but people suffering from MS didnt use Pure THC, they used cannabis which has a lot more than just THC. So they isolate one cannabinoid and call it cannabis. Funny, because its not even real THC, its synthetic THC. So yea not a big surprise fake THC didnt work, Very misleading headlines I cannot believe they can get away with that misinformation. The headline should of been ' Synthetic THC doesnt Halt MS progression'. (even though i thought cannabis doesnt halt but help sufferers manage their condition) MORE RESEARCH ON THE CANNABIS FLOWER BUD PLEASE. nature doesnt need changing!!

canna bis

Saturday 2nd June 2012 @ 14:45

The manner in which the findings of this study are being reported my the main-stream media is dangerously mis-leading. Especially for MS sufferers.



Despite this finding the THC (in synthesised, isolated form) does not halt the progression of MS.



Herbal Cannabis - in it's natural form, and (less effective) the drug Sativex remain HIGHLY EFFECTIVE treatments for the relief of the spasticity associated with Multiple Sclerosis.



More care must be taken when reporting on these issues to not promote mis-information and fear. Issues surrounding chronic pain-relief are issues of human rights and as such, legislation and public information surrounding them MUST be based in scientific fact NOT political agenda.


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016